Early toxicology insights for your crop products development

Early In Vivo Toxicology Testing, without ethical hurdles

Leverage a small non-vertebrate in vivo model to perform early-stage developmental and reproductive toxicity  assessments.

Accelerated Risk Identification

enables rapid screening of compounds for potential toxicological risks, delivering actionable insights early in the pipeline. This helps prioritize safer candidates, optimize resources, and reduce costs associated with late-stage failures.

Automation and High-content Data

streamlines testing workflows, allowing for the analysis of multiple compounds in parallel. Coupled with AI-driven analytics, Nagi Bioscience delivers consistent, user-independent results with robust data outputs that facilitate decision-making and enhance reproducibility.

Advancing Developmental and Reproductive Toxicity Testing: Scalable solutions for ethical and efficient agro-science innovations

The agro-science industry faces growing challenges in identifying toxicological risks early in the development pipeline while meeting regulatory and ethical constraints regarding testing methods. While essential for risk assessment, traditional vertebrate studies are costly, time-intensive, and raise ethical concerns.

Additionally, the lack of scalable in vivo methods for early-stage Developmental and Reproductive Toxicity (DART) testing limits the ability to efficiently prioritize safe and effective compounds. This results in resource inefficiencies, delays in innovation, and increased dependency on vertebrate studies.

Revolutionizing agro-science: Automated early-stage DART assessments

Nagi Bioscience offers the SydLab One platform as an innovative solution for agro-science. This fully automated system utilizes C. elegans, a validated in vivo model, to perform early-stage DART assessments. By identifying toxicological risks early, the platform reduces the number of vertebrate studies required and accelerates decision-making.

Its high-data content and throughput capabilities enable the screening of multiple compounds simultaneously, while automation ensures consistent and reproducible results. 

With actionable data delivered rapidly, Nagi Bioscience helps agro-science companies optimize their pipelines, improve cost efficiency, and maintain ethical standards without compromising on data quality.

Trusted by

Telomir Pharmaceuticals, aging

Access to an ever-growing number of peer-reviewed publications utilizing Nagi Bioscience solutions